Serax, the brand-name version of oxazepam, was not pulled from the market due to safety concerns or a regulatory action by the FDA. It was discontinued as a brand-name product for commercial reasons, a common outcome when a drug loses patent protection and generic versions take over the market. The active ingredient, oxazepam, remains FDA-approved and available in generic form today.
Why Brand-Name Drugs Get Discontinued
When a brand-name drug’s patent expires, generic manufacturers can produce the same medication at a fraction of the cost. Pharmacies, insurers, and patients overwhelmingly choose the cheaper generic, and sales of the brand-name version collapse. At that point, the original manufacturer often stops producing it because the product is no longer profitable. This is what happened with Serax. It wasn’t recalled, banned, or found to be unsafe. The brand simply became commercially irrelevant once generic oxazepam flooded the market.
This pattern plays out across the pharmaceutical industry. Dozens of well-known brand names disappear every decade for the same reason. The drug itself continues to exist, just under its generic name.
Generic Oxazepam Is Still Available
Generic oxazepam capsules in 10 mg, 15 mg, and 30 mg strengths are currently manufactured and sold in the United States. Teva Pharmaceuticals is one of the companies producing it, with FDA-approved labeling updated as recently as August 2023. Oxazepam remains classified as a Schedule IV controlled substance, meaning it requires a prescription and is recognized as having some potential for misuse, but less so than higher-schedule drugs.
If you were previously taking Serax, the generic version contains the same active ingredient at the same dose. There is no medical difference between the two.
What Oxazepam Is Used For
Oxazepam is a benzodiazepine prescribed primarily for anxiety, including anxiety related to depression, and for managing alcohol withdrawal symptoms. It’s also used to treat tension, agitation, and irritability in older adults. Typical doses range from 10 to 30 mg taken three or four times daily for anxiety, and 15 to 30 mg three or four times daily for alcohol withdrawal.
What makes oxazepam somewhat unusual among benzodiazepines is the way it’s processed by the body. Most benzodiazepines are broken down through a liver pathway called the cytochrome P450 system, which can be sluggish in older adults or people with liver problems. Oxazepam skips that step entirely. It’s already in its active form and gets cleared through a simpler process called glucuronidation, producing no active byproducts. This makes it a preferred choice for people with liver impairment or elderly patients who metabolize drugs more slowly.
Its half-life ranges from 3 to 21 hours, placing it in the short-to-intermediate category. It acts quickly but doesn’t linger in the body the way longer-acting benzodiazepines do.
Why Oxazepam Is Prescribed Less Often Now
Beyond the brand discontinuation, there’s a broader reason you hear less about oxazepam today: benzodiazepines as a class have been largely displaced as first-line anxiety treatments. SSRIs and SNRIs are now the standard starting point for generalized anxiety disorder, panic disorder, and social anxiety disorder. Drugs like escitalopram, sertraline, paroxetine, venlafaxine, and duloxetine all carry FDA approval for one or more of these conditions.
Buspirone is another non-benzodiazepine alternative approved for generalized anxiety, often tried before a prescriber would consider a benzodiazepine. In Europe, pregabalin is approved for anxiety as well.
Benzodiazepines haven’t disappeared from clinical use, but most guidelines now recommend them only after patients have tried and failed multiple rounds of SSRIs, SNRIs, or buspirone. When benzodiazepines are prescribed for panic disorder, higher-potency options like clonazepam and alprazolam tend to be chosen over oxazepam. This further narrowed oxazepam’s market, contributing to the commercial pressures that led to Serax’s discontinuation.
Risks That Apply to All Benzodiazepines
Oxazepam carries the same core risks as other drugs in its class. It can be habit-forming, particularly with prolonged use or higher-than-prescribed doses. People with a history of alcohol misuse, substance use, or depression face elevated risk. Combining oxazepam with opioid pain medications or certain cough medicines can cause life-threatening breathing problems, extreme sedation, or coma.
Common side effects include drowsiness, dizziness, headache, and frequent urination. More serious reactions, though rare, include severe skin rash, difficulty breathing or swallowing, yellowing of the skin or eyes, and irregular heartbeat. Stopping oxazepam abruptly after regular use can trigger withdrawal symptoms including seizures, anxiety, muscle twitching, and sleep problems.
These risks are not unique to oxazepam or the Serax brand. They apply broadly to benzodiazepines, and they’re a major reason the entire drug class has shifted from first-line treatment to a backup option in modern anxiety management.